Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 17INDUSTRY 2OTHER_GOV 1NIH 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Neoplasms 2873Carcinoma, Non-Small-Cell Lung 2426Breast Neoplasms 2067Colorectal Neoplasms 1245Neoplasm Metastasis 1231Prostatic Neoplasms 1080Melanoma 974Multiple Myeloma 963Ovarian Neoplasms 904Recurrence 852Leukemia, Myeloid, Acute 810Lung Neoplasms 757Pancreatic Neoplasms 752Lymphoma, Non-Hodgkin 727Lymphoma 660Stomach Neoplasms 623Carcinoma, Hepatocellular 566Carcinoma, Renal Cell 546Squamous Cell Carcinoma of Head and Neck 529Leukemia, Lymphocytic, Chronic, B-Cell 493Lymphoma, Follicular 468Head and Neck Neoplasms 451Glioblastoma 435Advanced Solid Tumors 432Small Cell Lung Carcinoma 411Triple Negative Breast Neoplasms 409Lymphoma, Large B-Cell, Diffuse 398Leukemia 394Uterine Cervical Neoplasms 369Advanced Solid Tumor 351

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Interventional × Hand-Foot Syndrome × Clear all
NCT01100463 2019-10-08

Study of 0.1% Uracil Topical Cream (UTC) for the Prevention of Hand-Foot Syndrome

Nanometics (d.b.a. PHD Biosciences)

Phase 1/2 Completed
18 enrolled
Breast

Breast Neoplasms, Hyaline Fibromatosis Syndrome, Hand-Foot Syndrome

NCT03612011 2019-09-06

OCRP

Quanta Medical

Phase 3 Completed
72 enrolled

Neoplasms, Hand-Foot Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡